Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
Clinical trial NCT03271047 · COMPLETED
Trial details
- NCT number
- NCT03271047
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-18
- Primary completion
- 2020-10-13
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.